About Morphle
Morphle is a Healthcare company based in Bengaluru (India) founded in 2017. Morphle has raised $5.15 million across 3 funding rounds from investors including HealthVenture, Y Combinator and Inflexor. Its website morphlelabs.com draws about 30 thousand monthly visits. Its Indian entity Morphle Labs Private Limited reported revenue of ₹14.25 Cr. Morphle offers products and services including Robotic Microtome, MorphoLens 1, MorphoLens 6, MorphoLens 240, and HemoLens 16. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Imaging Systems.
Company details
Provider of robotic microtomes and digital pathology scanners. These devices automate tissue processing and slide scanning for anatomical pathology, dermatopathology, and hematology. The scanners offer high-resolution imaging and integrated workflows, facilitating efficient digital microscopy and telepathology applications. Various models cater to different throughput needs, from single-slide to high-volume batch processing. The company also offers AI-powered requisition data entry solutions.
- Headquarters Bengaluru, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website morphlelabs.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Morphle Labs Private Limited
- Date of Incorporation 08 Jan, 2020
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹14.25 Cr
FY 2024 · +29% YoY
- Net Profit₹2.1 Lakh
FY 2024 · 0% margin
- EBITDA₹29.2 Lakh
FY 2024 · 2% margin
- Total Equity Funding$5.15M (USD)
in 3 rounds
- Latest Funding Round$5M (USD), Series A
Nov 2025
- InvestorsHealthVenture
& 2 more
Associated legal entities of Morphle
Morphle is associated with 2 registered companies on The Company Check; the primary company is Morphle Labs Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Morphle Labs Private Limited CIN U29309KA2020PTC131387 | Active | 08 Jan 2020 | Bangalore, Karnataka | ₹14.2 Cr | 73 | 2 | View details |
| Morphle Technologies Private Limited CIN U74999MH2017PTC298991 | Active | 24 Aug 2017 | Nagpur, Maharashtra | ₹1.0 Cr | 3 | View details |
Products & Services of Morphle
Morphle offers a comprehensive portfolio of products and services, including Robotic Microtome, MorphoLens 1, MorphoLens 6, MorphoLens 240, and HemoLens 16.
Automates tissue sectioning for high-throughput pathology
Scans single slides for tissue and cytology applications
Handles up to 100 slides daily for digital microscopy
Processes high-volume batches for histopathology workflows
Specialized for hematology and bone marrow analysis
Apps and channels of Morphle
its YouTube channel Morphle Slide Scanners has 279 subscribers and 7 videos.
Videos from Morphle
The most watched videos on Morphle's YouTube channel, Morphle Slide Scanners (279 subscribers). Click a video to play it here.
More on Morphle Slide Scanners.
Funding Insights of Morphle
Morphle has successfully raised a total of $5.15M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.15M
- Total Rounds 3
- Last Round Series A — $5M
- First Round $150,000
(Mar 2020)
- Investors Count 3
All 3 funding rounds of Morphle with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2025 | $5M | Series A | – | Inflexor | – |
| Sep 2021 | $75,000 | Grant | – | – | |
| Mar 2020 | $150,000 | Seed | – | Y Combinator | – |
3 investors in total: 3 institutional.
Investors in Morphle
Morphle has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include HealthVenture, Y Combinator and Inflexor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare focused incubator and VC firm | healthventure.com | New Haven, United States | ||
Early-stage startups are accelerated via funding and educational programs. | ycombinator.com | Mountain View, United States | ||
Venture capital firm investing in technology and deep tech startups with a focus on innovative solutions. | inflexor.vc |
Investor details for Morphle
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Morphle Labs Private Limited (Morphle)
Morphle Labs Private Limited is the primary company behind Morphle. The boards of the 2 registered companies of Morphle currently have 3 directors; the longest-serving is Anchit Vidyut Navelkar, appointed in 2017. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anchit Vidyut Navelkar DIN 07918303 | Director | 24 Aug 2017 | 9 yrs 2 mo | Morphle Technologies Private Limited |
| Rohit Ramesh Hiwale DIN 07262536 | Director | 08 Jan 2020 | 6 yrs 10 mo | Morphle Labs Private Limited, Morphle Technologies Private Limited |
| Ashish Hariram Manmode DIN 07546151 | Director | 21 Oct 2021 | 5 yrs | Morphle Labs Private Limited, Morphle Technologies Private Limited |
People of Morphle
11 people are tracked at Morphle (3 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Sunnel Daniel | VP - Sales | Leadership |
| VP - Software | Leadership | |
| CEO | Leadership | |
AKSHAY KUMAR | Operations and supply chain Manager | Team |
Sachin S L | Production Quality Engineer | Team |
Anvesha Shrivastava | Enterprise Sales Specialist | Team |
Yashesh Mankad | Full Stack Developer | Team |
Pavan kumar Motupalli | Production Team Lead | Team |
Naveenraj G | Sales Support Engineer | Team |
Jayant Patidar | Senior Software Engineer | Team |
Akshay M | Assembly Engineer | Team |
Complete people profiles for Morphle
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Morphle
Figures of Morphle Labs Private Limited, the primary company behind Morphle, for FY 2024. Revenue was ₹14.25 Cr (+29% year on year). Net profit was ₹2.1 Lakh (0% margin). EBITDA was ₹29.2 Lakh (2% margin). Revenue has grown at a compounded annual rate of +80% over three years.
- ₹14.25 CrRevenue · FY 2024 · +29% YoY
- ₹2.1 LakhNet profit · 0% margin
- ₹29.2 LakhEBITDA · 2% margin
- ₹1.2 LakhPaid-up capital
- 73Employees (provident fund records)
- +80%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Morphle Labs Private Limited are on its company page.
Detailed financial statements for Morphle
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Morphle
3 dated milestones of Morphle across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Morphle is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Series A, of $5.0M.
Web traffic of Morphle
The website of Morphle (morphlelabs.com) receives about 29.7K visits a month.
- Monthly visits29.7K
▲ 278.4% vs previous month
Websites whose visitors overlap most with Morphle. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
proximusmedical.com | proximusmedical.com | 100% | #11,377,539 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Morphle
Complete news archive for Morphle
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Morphle
Morphle was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Morphle is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Morphle is a funded company, having raised a total of $5.15M across 3 funding rounds to date. The company's 1st funding round was a Seed of $150K, raised on Mar 2020.
The primary company behind Morphle, Morphle Labs Private Limited, reported revenue of ₹14.25 Cr for FY 2024, up 29% year on year.
Provider of robotic microtomes and digital pathology scanners. These devices automate tissue processing and slide scanning for anatomical pathology, dermatopathology, and hematology. The scanners offer high-resolution imaging and integrated workflows, facilitating efficient digital microscopy and telepathology applications. Various models cater to different throughput needs, from single-slide to high-volume batch processing. The company also offers AI-powered requisition data entry solutions.
Morphle offers Robotic Microtome, MorphoLens 1, MorphoLens 6, MorphoLens 240, and HemoLens 16.
Morphle has 3 investors. Key investors include HealthVenture, Y Combinator, and Inflexor.
Morphle is associated with 2 legal entities: Morphle Labs Private Limited, Morphle Technologies Private Limited.
The legal entities of Morphle currently have 3 directors, including Rohit Ramesh Hiwale, Ashish Hariram Manmode, Anchit Vidyut Navelkar.